HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Equity Capital Markets

Pu'er Lancang Ancient Tea / Equity Capital Markets

<ul>
<li>Traditional tea companies are rarely seen in China's secondary market. The most significant issue in the domestic tea industry is product standardization, leading to obvious bottlenecks in future revenue/profit scale. </li>
<li>Despite increasing investment in sales/marketing, financial results of Lancang haven’t shown much improvement. Sales of 1966 products would continue to be under pressure due to weak demand during economic downturn.</li>
<li>Lancang’s financial performance is unsatisfactory, with declining revenue growth and profit margin. We are not optimistic about the Company's prospects. Valuation should be lower than <a href="https://www.smartkarma.com/entities/nayuki-holdings" target="_blank" data-smartkarma-citation="entities:32149:1" rel="noopener">Nayuki Holdings (2150 HK).</a>
</li>
</ul>


Traditional tea companies are rarely seen in China's secondary market. The most significant issue in the domestic tea industry is product standardization, leading to obvious bottlenecks in future revenue/profit scale. 
Despite increasing investment in sales/marketing, financial results of Lancang haven’t shown much improvement. Sales of 1966 products would continue to be under pressure due to weak demand during economic downturn.
Lancang’s financial performance is unsatisfactory, with declining revenue growth and profit margin. We are not optimistic about the Company's prospects. Valuation should be lower than Nayuki Holdings (2150 HK).



Pre-IPO Pu'er Lancang Ancient Tea (PHIP Updates) - Lack of Product Standardization Is the Pain Point

China

Pu'er Lancang Ancient Tea Co., Ltd. manufactures and distributes tea products. The Company produces cooked tea, raw tea, seasoned tea, and other products. Pu'er Lancang Ancient Tea also produces tea sets.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Pu'er Lancang Ancient Tea (PLAT HK)

Pre-IPO Pu'er Lancang Ancient Tea (PHIP Updates) - Lack of Product Standardization Is the Pain Point

Due to lack of product standardization, weak marketing, poor cost control, there're obvious growth bottleneck in Lancang's revenue scale. Profit...

Xinyao (Criss) Wang

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)